# ZenithCred â€” Benelux VC Research
*Compiled: 9 Feb 2026*

**Company:** ZenithCred â€” Corporate wellness gamification platform (light panels + biofeedback + gamification tokens)
**Round:** Seed â‚¬1.1M | Pre-money valuation target â‚¬2.5â€“3.5M

---

## BENELUX VCs (20)

### ðŸ‡³ðŸ‡± NETHERLANDS

---

#### 1. NLC Health Ventures
| | |
|---|---|
| **Location** | North Holland, Netherlands |
| **Website** | [nlc.health](https://www.nlc.health) |
| **Focus** | Healthtech venture builder â€” co-founds and invests in 20-25 ventures/year across cardiovascular, orthopedics, therapeutics, and new health markets |
| **Check size** | From â‚¬25K (venture building model); â‚¬160M+ raised across 110+ ventures |
| **Portfolio** | 110+ ventures built; 2.4M+ patients impacted; B Corp certified |
| **Contact** | Via website â€” operates with 80+ in-house experts |
| **ZenithCred fit** | Venture-builder model ideal for hardware+software hybrid; deep health ecosystem; could help productize biofeedback components and provide regulatory/clinical support |

---

#### 2. Nextgen Ventures
| | |
|---|---|
| **Location** | Netherlands |
| **Website** | [nextgenventures.nl](https://www.nextgenventures.nl) |
| **Focus** | Early-stage digital health and medtech in NL, Germany, Belgium â€” Quadruple Aim (patient experience, population health, cost reduction, provider satisfaction) |
| **Check size** | â‚¬500Kâ€“â‚¬1.5M (seed/first ticket) |
| **Portfolio** | ~19 investments: Momo Medical (night care tech), Manometric 3D (AI/3D-printed prostheses) |
| **Contact** | Backed by Invest-NL (â‚¬5M), Noaber Ventures, Triade |
| **ZenithCred fit** | **Top fit.** Perfect check size for â‚¬1.1M seed. Focus on digital health + hardware solutions. Corporate wellness aligns with Quadruple Aim thesis (population health, cost reduction). NL/Belgium/Germany geographic match. |

---

#### 3. INKEF Capital
| | |
|---|---|
| **Location** | Amsterdam, Netherlands |
| **Website** | [inkef.com](https://www.inkef.com) |
| **Focus** | Early-stage VC â€” healthcare (digital health, therapeutics, medical devices) + technology (AI, fintech, deep tech) |
| **Check size** | Primarily Series A but does seed for exceptional teams |
| **Portfolio** | 43+ investments, 6 exits: Castor EDC, Aidence (AI imaging), iOnctura, ONWARD |
| **Contact** | Team includes Partners, Venture Partner, Principal; Najma Labyad (listed) |
| **ZenithCred fit** | Digital health + IoT/hardware overlap; Amsterdam ecosystem connections; may be stretch for pure seed but worth pitching the biofeedback tech angle |

---

#### 4. Thuja Capital
| | |
|---|---|
| **Location** | Utrecht, Netherlands |
| **Website** | [thujacapital.com](https://www.thujacapital.com) |
| **Focus** | Pre-seed and seed healthcare â€” digital health, medtech, biotech, nutraceuticals; emphasis on clinical validation |
| **Check size** | Not publicly disclosed; 5 funds managed |
| **Portfolio** | Focus on NL and Belgium; clinical-impact innovations |
| **Contact** | Michel Briejer, Maike Schepens, EstefanÃ­a Matesanz (COO), Evan Castiglia, Eline van Beest (Venture Partner) |
| **ZenithCred fit** | Pre-seed/seed stage match; biofeedback clinical validation angle; Utrecht Science Park proximity to research talent; Benelux focus |

---

#### 5. Gilde Healthcare
| | |
|---|---|
| **Location** | Utrecht, Netherlands |
| **Website** | [gildehealthcare.com](https://gildehealthcare.com) |
| **Focus** | Healthtech, therapeutics, healthcare â€” â‚¬2.6B+ AUM; Venture & Growth fund |
| **Check size** | â‚¬10â€“40M per company (primarily Series A+); too large for seed but valuable for follow-on |
| **Portfolio** | 63 companies: Mainstay Medical, NightBalance |
| **Contact** | Pieter van der Meer (Managing Partner), +31 (0)30 219 2565 |
| **ZenithCred fit** | **Follow-on investor** for Series A. Worth building relationship now. Strong healthtech thesis and ecosystem. Could validate ZenithCred for smaller seed investors. |

---

#### 6. LUMO Labs
| | |
|---|---|
| **Location** | Eindhoven, Netherlands |
| **Website** | [lumolabs.io](https://lumolabs.io) |
| **Focus** | Pre-seed and seed in AI-driven healthtech and deep tech; manages â‚¬100M Lumo Rise Fund + â‚¬8M TTT.AI fund for Dutch AI spin-offs |
| **Check size** | Pre-seed to seed; portfolio rounds typically â‚¬1â€“2.5M |
| **Portfolio** | 31 investments (9 healthcare): Autoscriber, Healthplus.ai, Surgical Reality, Aiosyn |
| **Contact** | Based in Brainport Eindhoven ecosystem |
| **ZenithCred fit** | AI/deep-tech + health intersection; biofeedback data analytics angle; Eindhoven hardware ecosystem (Philips, ASML region); seed-stage match |

---

#### 7. Borski Fund
| | |
|---|---|
| **Location** | Amsterdam, Netherlands |
| **Website** | [borskifund.com](https://borskifund.com) |
| **Focus** | Early-stage Dutch/European tech; emphasis on diverse founding teams; â‚¬21M fund |
| **Check size** | â‚¬0â€“1M seed rounds |
| **Portfolio** | 18-21 investments (7 healthcare): Root Sustainability, The Selection Lab |
| **Contact** | Via website |
| **ZenithCred fit** | Healthcare is their largest sector; seed-stage match; Amsterdam network; diversity angle if applicable. Smaller check could be part of syndicate. |

---

#### 8. Peak Capital
| | |
|---|---|
| **Location** | Amsterdam, Netherlands |
| **Website** | [peak.capital](https://peak.capital) |
| **Focus** | Seed-stage SaaS, marketplaces, platforms across Europe (Benelux, DACH, Nordics); â‚¬150M Fund V |
| **Check size** | â‚¬250Kâ€“â‚¬4M |
| **Portfolio** | 50+ investments: Catawiki, Hygraph, StuDocu |
| **Contact** | Founded by entrepreneurs; offices in Amsterdam, Berlin, Stockholm |
| **ZenithCred fit** | Strong B2B SaaS thesis â€” ZenithCred's gamification platform/token system fits the platform model. Not health-specific but seed check size is ideal. Enterprise wellness = SaaS recurring revenue story. |

---

### ðŸ‡§ðŸ‡ª BELGIUM

---

#### 9. HERAN Partners
| | |
|---|---|
| **Location** | Belgium |
| **Website** | [heranpartners.com](https://www.heranpartners.com) |
| **Focus** | European HealthTech â€” MedTech, digital health; venture and growth capital with mentorship; â‚¬45M Fund I |
| **Check size** | Co-led rounds of â‚¬5â€“20M; likely â‚¬1â€“5M initial tickets |
| **Portfolio** | Amaron, icometrix, LynxCare, ONTOFORCE, Thirona, BlueBee, Nuclivision |
| **Contact** | Via website; co-invests with LUMO Labs, Capricorn, PMV |
| **ZenithCred fit** | **Strong fit.** Digital health focus with strong tech platform requirement matches biofeedback+gamification. Mentorship model adds value. Benelux ecosystem connector. |

---

#### 10. Capricorn Partners (Healthtech Fund II)
| | |
|---|---|
| **Location** | Leuven, Belgium |
| **Website** | [capricorn.be](https://capricorn.be) |
| **Focus** | Digital health, medtech, health software platforms; late seed to Series B; â‚¬51M first close (targeting â‚¬100M+) |
| **Check size** | â‚¬1â€“5M per deal in 10-15 European companies |
| **Portfolio** | 11 active, 7 exits: icometrix, Bingli, Neotiv, DEO Care; exits include Cartagenia, Bluebee, Sequana Medical |
| **Contact** | Filip Pintelon, Dick den Hertog, Antoine D'Hollander |
| **ZenithCred fit** | **Top fit.** Late-seed sweet spot matches ZenithCred's stage. Digital health software + medtech combination is exact thesis match. Leuven research ecosystem. Backed by Invest-NL, PMV, AG Insurance. |

---

#### 11. Volta Ventures
| | |
|---|---|
| **Location** | Ghent, Belgium (+ Amsterdam office) |
| **Website** | [volta.ventures](https://www.volta.ventures) |
| **Focus** | Seed-stage B2B SaaS and internet/software in Benelux; â‚¬20M AI-first fund + Fund II (â‚¬39.2M) |
| **Check size** | â‚¬100Kâ€“â‚¬1M initial, substantial follow-on |
| **Portfolio** | 60+ investments: Sentiance, Spotr.ai, AxonIQ, Cashforce, Sweepbright, Segments.ai |
| **Contact** | Offices in Ghent and Amsterdam |
| **ZenithCred fit** | **Strong fit.** Benelux B2B SaaS thesis; Sentiance (behavioral data) in portfolio shows health-adjacent interest. Check size matches seed round. Amsterdam + Ghent presence for both NL and BE markets. |

---

#### 12. PMV
| | |
|---|---|
| **Location** | Flanders, Belgium |
| **Website** | [pmv.eu](https://www.pmv.eu) |
| **Focus** | Flemish investment company â€” seed to growth in healthtech, biotech, medtech, e-health; â‚¬1.9B total portfolio |
| **Check size** | Up to â‚¬5M for early-stage; co-leads larger rounds |
| **Portfolio** | Aspect Analytics, Sequana Medical; invests directly + via specialized funds |
| **Contact** | Via pmv.eu; co-invests with Capricorn, HERAN |
| **ZenithCred fit** | Government-backed patient capital; e-health is explicit focus; could anchor round with institutional credibility. Long-term support from startup to growth. |

---

#### 13. Noshaq (formerly Meusinvest)
| | |
|---|---|
| **Location** | LiÃ¨ge, Belgium |
| **Website** | [noshaq.be](https://noshaq.be) |
| **Focus** | SME financing across biotech, healthtech, pharma, digital, Industry 4.0; â‚¬700M share capital; 478 portfolio companies |
| **Check size** | Average ~â‚¬830K; max â‚¬25M; tailored to stage |
| **Portfolio** | 478 companies; subsidiaries: LeanSquare (digital/life sciences), White Fund (medical devices), Noshaq Venture (startups) |
| **Contact** | info@leansquare.be, +32 (0)4 221 62 11 (LeanSquare arm) |
| **ZenithCred fit** | LeanSquare fund specifically targets life sciences + digital intersection at seed/Series A. Average check ~â‚¬830K fits well in ZenithCred's round. Wallonia regional support adds ecosystem value. |

---

#### 14. Qbic Fund
| | |
|---|---|
| **Location** | Ghent, Belgium |
| **Website** | [qbic.be](https://www.qbic.be) |
| **Focus** | University spin-offs from Ghent, Brussels, Antwerp â€” biotech, healthtech, AI, deep tech; â‚¬190M across 3 funds |
| **Check size** | Seed and early-stage; Fund III actively deploying |
| **Portfolio** | ~55 investments: moveUP (remote surgical care), Cascador Health, Spica Therapeutics, Tanai Therapeutics |
| **Contact** | Via qbic.be |
| **ZenithCred fit** | If ZenithCred has university research ties (biofeedback, light therapy), Qbic could be ideal. moveUP (remote care) shows digital health interest. Strong Belgian ecosystem connector. |

---

#### 15. Gimv
| | |
|---|---|
| **Location** | Antwerp, Belgium |
| **Website** | [gimv.com](https://www.gimv.com) |
| **Focus** | Healthcare platform (one of four core platforms) â€” ~60 companies, â‚¬4.5B combined turnover; invests across consumer, smart industries, sustainable cities |
| **Check size** | Typically larger (growth stage); â‚¬4.5B portfolio |
| **Portfolio** | Onera (remote sleep diagnostics), FIRE1 (heart failure monitoring); winding down life sciences but maintaining healthcare |
| **Contact** | Via gimv.com |
| **ZenithCred fit** | Onera (sleep diagnostics) and FIRE1 (biometric monitoring) show direct relevance to biofeedback. Smart industries platform could cover hardware+IoT angle. Better as Series A/B follow-on partner. |

---

#### 16. Verlinvest
| | |
|---|---|
| **Location** | Brussels, Belgium |
| **Website** | [verlinvest.com](https://www.verlinvest.com) |
| **Focus** | Consumer health, wellness, food, beverage; $4B+ AUM; patient permanent capital from family office |
| **Check size** | Growth-stage (â‚¬20M+); V3 Ventures arm for earlier stages |
| **Portfolio** | Oatly, Vita Coco, Genexa (consumer health), Sinomedica, Yepoda |
| **Contact** | Brussels HQ (18 Place EugÃ¨ne Flagey), + London, New York, Singapore |
| **ZenithCred fit** | Consumer wellness DNA; V3 Ventures arm for earlier-stage. Best approached once ZenithCred has B2C consumer wellness angle or employee benefit distribution. Brand-building expertise. |

---

#### 17. Sofina
| | |
|---|---|
| **Location** | Brussels, Belgium |
| **Website** | [sofinagroup.com](https://www.sofinagroup.com) |
| **Focus** | Healthcare/life sciences, digital transformation, consumer/retail; â‚¬10.3B NAV |
| **Check size** | â‚¬20â€“100M (Series B+); too large for seed |
| **Portfolio** | HealthKart, Twin Health, Included Health, Carebridge, Oviva |
| **Contact** | Brussels HQ + Luxembourg, Singapore offices |
| **ZenithCred fit** | **Later-stage only.** Included Health (employer healthcare platform) and Twin Health (digital twin for health) show thesis alignment. Valuable Series A/B target. Build relationship early. |

---

#### 18. V-Bio Ventures
| | |
|---|---|
| **Location** | Ghent, Belgium |
| **Website** | [v-bio.ventures](https://www.v-bio.ventures) |
| **Focus** | Life sciences seed to Series B in Europe; strong ties to VIB research institute |
| **Check size** | Seed to Series B; typically co-invests |
| **Portfolio** | Animab (cancer nanotech), multiple biotech exits |
| **Contact** | Via website |
| **ZenithCred fit** | If biofeedback technology has life sciences IP component, V-Bio could add scientific credibility. University/research institute network valuable for clinical validation of light panel and biofeedback claims. |

---

### ðŸ‡±ðŸ‡º LUXEMBOURG

---

#### 19. Exor Ventures
| | |
|---|---|
| **Location** | Luxembourg (Agnelli family holding) |
| **Website** | [exor.com](https://www.exor.com) |
| **Focus** | Pre-seed to growth in digital health, technology, consumer |
| **Check size** | Flexible; pre-seed through growth |
| **Portfolio** | Broad tech portfolio; digital health investments noted |
| **Contact** | Via exor.com |
| **ZenithCred fit** | Patient family-office capital; digital health interest; Luxembourg presence completes Benelux coverage. Could provide follow-on capacity. |

---

#### 20. LeanSquare (Noshaq subsidiary)
| | |
|---|---|
| **Location** | LiÃ¨ge, Belgium (operates across Benelux) |
| **Website** | [leansquare.be](https://leansquare.be) |
| **Focus** | Digital startups in Life Sciences, software, entertainment; seed/Series A; â‚¬13M+ invested in 65+ startups |
| **Check size** | Seed to Series A; part of â‚¬13M+ deployment |
| **Portfolio** | 40+ active companies across Belgium, France, UK, US, Germany |
| **Contact** | info@leansquare.be, +32 (0)4 221 62 11 |
| **ZenithCred fit** | **Strong fit.** Life Sciences + digital intersection is core thesis. Seed stage focus. Part of Noshaq ecosystem (â‚¬700M group) provides follow-on and ecosystem access. Active in Benelux. |

---

## EU-WIDE VCs WITH BENELUX ACTIVITY (5)

---

#### 21. naturalX Health Ventures
| | |
|---|---|
| **Location** | Berlin, Germany |
| **Website** | [naturalx.vc](https://www.naturalx.vc) |
| **Focus** | Consumer health at the wellness-medicine intersection â€” sleep, gut health, prevention, longevity, mental health; â‚¬100M debut fund (Feb 2025) |
| **Check size** | â‚¬3â€“5M initial (Series A focus); up to â‚¬10M per company |
| **Portfolio** | mybacs, Flow Neuroscience (brain stimulation for depression), Kyan Health (mental wellness), Meela |
| **Contact** | Marvin Amberg (Founder/MD); backed by Schwabe Group |
| **ZenithCred fit** | **Top EU-wide fit.** Flow Neuroscience (brain stimulation) is directly analogous to ZenithCred's light panels + biofeedback. Prevention/wellness thesis. Check may be larger than needed but could lead a round. Wellness-medicine bridge is exact positioning. |

---

#### 22. Calm/Storm Ventures
| | |
|---|---|
| **Location** | Vienna, Austria |
| **Website** | [calmstorm.vc](https://www.calmstorm.vc) |
| **Focus** | Super-early-stage digital health and wellness â€” mental health, fertility, chronic conditions, prevention; â‚¬30M fund; most active early-stage HealthTech investor in Europe (2022-2024) |
| **Check size** | Pre-seed and seed (amounts not public) |
| **Portfolio** | 75+ companies: Thymia (AI mental health), Fertifa (employer reproductive benefits), Nolea Health, Suvera, 9am.health |
| **Contact** | Via website; backed by SwissHealth Ventures |
| **ZenithCred fit** | **Top EU-wide fit.** Employer wellness benefits (Fertifa) in portfolio shows B2B wellness thesis. Most active early-stage health VC in Europe. Prevention focus. Founder network of 75+ healthtech companies for partnerships. |

---

#### 23. Ananda Impact Ventures
| | |
|---|---|
| **Location** | Munich, Germany (+ London, Berlin) |
| **Website** | [ananda.vc](https://ananda.vc) |
| **Focus** | Impact VC â€” healthtech, sustainability, social innovation; pre-seed to Series A; DACH + Benelux + UK + Nordics; ~â‚¬270M AUM |
| **Check size** | â‚¬500Kâ€“â‚¬3M initial; up to â‚¬8â€“10M follow-on |
| **Portfolio** | 52+ investments (24 healthcare): IESO Digital Health, Close Loop Medicine, NatureMetrics, OroraTech |
| **Contact** | Florian Erber & Johannes Weber (Co-founders); HQ Isarwinkel 6, Munich |
| **ZenithCred fit** | **Strong fit.** Explicit Benelux geography. Impact thesis matches corporate wellness (employee health = social impact). Check size ideal for â‚¬1.1M seed. Could lead round. B Corp-aligned values. |

---

#### 24. Karista VC
| | |
|---|---|
| **Location** | Paris, France |
| **Website** | [karista.vc](https://www.karista.vc) |
| **Focus** | European healthtech â€” software in healthcare, augmented medical devices, patient data; seed to Series B |
| **Check size** | â‚¬500Kâ€“â‚¬5M initial; up to â‚¬10M follow-on |
| **Portfolio** | Incepto Medical, Kranus Health, Brightflow, DEO Care, MyPL; invested in Belgian TiHive (2025) |
| **Contact** | Via karista.vc; co-invests with Turenne Capital, WE Life Sciences |
| **ZenithCred fit** | "Augmented medical devices" category fits biofeedback hardware. Active in Belgium (TiHive investment). Software in healthcare thesis matches gamification platform. Leads rounds and takes board seats. |

---

#### 25. YZR Capital
| | |
|---|---|
| **Location** | Munich, Germany |
| **Website** | [yzr-capital.com](https://yzr-capital.com) |
| **Focus** | Early-stage European healthtech â€” efficiency, transparency, patient care; pre-seed to Series A |
| **Check size** | â‚¬100Kâ€“â‚¬1.5M |
| **Portfolio** | Deepeye Medical, Doctor.One, IMA, OpenHealth |
| **Contact** | Markus Feuerecker & Reinhard Meier (Founders); backed by Beiersdorf, Bertelsmann, EIF, KfW Capital |
| **ZenithCred fit** | Healthtech efficiency thesis fits corporate wellness ROI story. Check size matches. European focus with regulatory expertise. Could validate biofeedback claims from health-economics angle. |

---

## PRIORITY TIER SUMMARY

### ðŸ”´ Tier 1 â€” Approach First (strongest fit)
1. **Nextgen Ventures** (NL) â€” Perfect stage, check size, digital health + hardware thesis
2. **Capricorn Healthtech Fund II** (BE) â€” Late-seed sweet spot, digital health software, â‚¬1-5M checks
3. **Volta Ventures** (BE/NL) â€” B2B SaaS thesis, Benelux focus, Sentiance portfolio synergy
4. **Calm/Storm Ventures** (EU) â€” Most active early-stage health VC, employer wellness in portfolio
5. **Ananda Impact Ventures** (EU) â€” Impact thesis, explicit Benelux, ideal check size
6. **LeanSquare/Noshaq** (BE) â€” Life sciences + digital, seed focus, â‚¬700M group backing

### ðŸŸ¡ Tier 2 â€” Strong Fit
7. **HERAN Partners** (BE) â€” Digital health + mentorship
8. **naturalX Health Ventures** (EU) â€” Flow Neuroscience in portfolio (brain stimulation)
9. **LUMO Labs** (NL) â€” AI health + deep tech, Eindhoven hardware ecosystem
10. **Peak Capital** (NL) â€” B2B SaaS platform thesis, â‚¬250K-4M checks
11. **Karista VC** (EU) â€” Augmented medical devices, Belgium activity
12. **PMV** (BE) â€” Institutional anchor, e-health focus

### ðŸŸ¢ Tier 3 â€” Relationship Building / Follow-on
13. **NLC Health Ventures** (NL) â€” Venture builder model, long game
14. **Thuja Capital** (NL) â€” Pre-seed/seed health, clinical validation
15. **YZR Capital** (EU) â€” Smaller checks, healthtech efficiency
16. **Borski Fund** (NL) â€” Healthcare sector focus, smaller checks
17. **Qbic Fund** (BE) â€” If university research ties exist
18. **INKEF Capital** (NL) â€” Series A target for follow-on
19. **Gilde Healthcare** (NL) â€” Series A/B follow-on
20. **V-Bio Ventures** (BE) â€” Life sciences IP angle

### âšª Tier 4 â€” Later Stage (Series A+)
21. **Gimv** (BE) â€” Sleep/biometric portfolio relevance
22. **Sofina** (BE) â€” Digital health platforms at scale
23. **Verlinvest** (BE) â€” Consumer wellness brand building
24. **Exor Ventures** (LU) â€” Patient family capital

---

## OUTREACH RECOMMENDATIONS

1. **Lead with the B2B SaaS story** for generalist funds (Peak, Volta) â€” recurring revenue, enterprise contracts
2. **Lead with the health-tech/biofeedback story** for health funds (Nextgen, Capricorn, HERAN) â€” clinical validation, employee health outcomes
3. **Lead with impact metrics** for impact funds (Ananda, Calm/Storm) â€” employee wellness outcomes, preventive health ROI
4. **Build a syndicate** â€” Target 2-3 Tier 1 funds for â‚¬300-500K each to fill the â‚¬1.1M round
5. **Request warm intros** â€” Capricorn and HERAN frequently co-invest; one intro can unlock both
6. **Apply to Calm/Storm's founder network** â€” Even pre-investment, the 75+ healthtech founder community adds massive value

---

*Note: Check sizes and portfolio details based on publicly available information as of Feb 2026. Always verify current fund status and investment appetite before outreach.*
